Aditum Bio
Finance · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1111 Broadway Ste 1300, Oakland, Califor...Phone Number
(510) 227-2102Website
www.aditumbio.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
3
3
3
2
About Aditum Bio
Aditum Bio is a biotech venture capital firm focused on rapidly translating scientific discoveries into innovative medicines. The company aims to bridge the gap between scientific research and patient care, benefiting patients through its investments. Aditum Bio is uniquely positioned to drive advancements in the biotech industry. Their intended clients include researchers and companies in the life sciences sector seeking funding and support for their innovations.Explore more
Aditum Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aditum Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Aditum Bio had a recent Job posting/layoffs
Aditum Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Aditum Bio launches new products
Congratulate Masked Content for being promoted to Masked Content at Aditum Bio
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Aditum Bio has new funding data
Check if Aditum Bio has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Aditum Bio recently announced quarterly report
Check out if Aditum Bio is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Aditum Bio as Masked Content
Find 3 more new buyers
Compare Similar Companies to Aditum Bio
Compare insights from companies similar to Aditum Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aditum Bio is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Aditum Bio is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Aditum Bio.
Aditum Bio Tech Stack
A closer look at the technologies used by Aditum Bio
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Aditum Bio News & Media
Tempero Bio Secures $70 Million Series B Financing to Advance TMP-301 into Phase 2 Trials for Substance Use Disorders
Funding will support two Phase 2 clinical trials in alcohol and cocaine use disorders Company has initiated Phase 2 study in alcohol use disorder and plans to initiate cocaine studies over the next year John Wagner M.D., Ph.D. to join as Chief Medical Officer OAKLAND, Calif., March 24,...Aditum Bio and Leads Biolabs Announce the Formation of Oblenio Bio to Develop a Tri-Specific T-Cell Engager for Autoimmune Disorders
Leads Biolabs grants Oblenio Bio an exclusive option to license LBL-051, a first-in-class CD19xBCMAxCD3 tri-specific T-cell engager antibody OAKLAND, Calif. and NANJING, China, Nov. 7, 2024 /PRNewswire/ -- Aditum Bio and Leads Biolabs today announced the formation of Oblenio Bio, which is...Aditum Bio Announces Formation of Celexor Bio, Focused on Cell Depletion of Pathologic Cells in Autoimmune and Inflammatory Disorders
Celexor Bio is the tenth company formed by Aditum Bio OAKLAND, Calif. , Sept. 21, 2023 /PRNewswire/ -- Aditum Bio, the biotech investment firm cofounded in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for BioMedical Research (NIBR) Dr. Mark...Inmagene announces formation of Celexor Bio based on its anti-ILT7 mAb with enhanced pDC depletion function
SAN DIEGO, Sept. 21, 2023 /PRNewswire/ -- Inmagene Biopharmaceuticals (Inmagene), a clinical-stage biotech company developing innovative and differentiated therapies for immunological and inflammatory diseases, today announced its partnership with Aditum Bio to create Celexor Bio (Celexor), a new biotech company focused on cell depletion of pathologic cells in autoimmune and inflammatory disorders. Celexor has been formed based on Inmagene's IMG-018, a pDC depleting antibody targeting immunoglob
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aditum Bio
Sign Up For FreeTo access detailed company insights
Aditum Bio is a biotech venture capital firm focused on rapidly translating scientific discoveries into innovative medicines. The company aims to bridge the gap between scientific research and patient care, benefiting patients through its investments. Aditum Bio is uniquely positioned to drive advancements in the biotech industry. Their intended cl... Read More
